Stoke Therapeutics (STOK) Assets Average: 2022-2025
Historic Assets Average for Stoke Therapeutics (STOK) over the last 4 years, with Sep 2025 value amounting to $372.4 million.
- Stoke Therapeutics' Assets Average rose 23.91% to $372.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $372.4 million, marking a year-over-year increase of 23.91%. This contributed to the annual value of $249.9 million for FY2024, which is 3.20% up from last year.
- As of Q3 2025, Stoke Therapeutics' Assets Average stood at $372.4 million, which was down 5.89% from $395.7 million recorded in Q2 2025.
- In the past 5 years, Stoke Therapeutics' Assets Average ranged from a high of $395.7 million in Q2 2025 and a low of $216.8 million during Q1 2024.
- In the last 3 years, Stoke Therapeutics' Assets Average had a median value of $269.4 million in 2023 and averaged $289.5 million.
- Per our database at Business Quant, Stoke Therapeutics' Assets Average decreased by 19.40% in 2024 and then soared by 56.49% in 2025.
- Stoke Therapeutics' Assets Average (Quarterly) stood at $266.8 million in 2022, then decreased by 12.27% to $234.1 million in 2023, then grew by 20.64% to $282.4 million in 2024, then climbed by 23.91% to $372.4 million in 2025.
- Its Assets Average was $372.4 million in Q3 2025, compared to $395.7 million in Q2 2025 and $339.2 million in Q1 2025.